6/20/2019  5:44:24 PM Chg. +1.000 Volume Bid7:29:38 PM Ask7:29:38 PM Market Capitalization Dividend Y. P/E Ratio
71.380EUR +1.42% 403
Turnover: 28,811.340
71.280Bid Size: 200 71.440Ask Size: 200 21.67 bill.EUR 1.66% 10.88

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
 

Management board & Supervisory board

CEO
Rice Powell
Management board
Michael Brosnan, Dr. Katarzyna Mazur-Hofsaess, Dr. Olaf Schermeier, Harry de Wit, Kent Wanzek, William Valle
Supervisory board
Dr. Dieter Schenk, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon, William P. Johnston
 

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 56.49%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49-6172-609-2601
IR-Fax: -
IR e-mail: ir@fmc-ag.com

Company calendar

CW 31 | 7/30/2019 Interim Report 2nd Quarter/6 Months
CW 44 | 10/29/2019 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
56.49%
Fresenius SE & Co. KGaA
 
30.75%
Thornburg Investment Management Inc.
 
4.96%
BlackRock, Inc.
 
4.83%
Norges Bank
 
2.97%
Others
 
0.00%